How to Get Tadalafil (Generic) in Idaho

At a glance
- Telehealth prescribing legal in Idaho / no prior in-person visit required
- Available doses / 2.5 mg, 5 mg, 10 mg, 20 mg oral tablets
- Idaho Medicaid coverage / not covered for ED or BPH
- 503A compounding pharmacies / licensed and able to ship within Idaho
- Prescriber types allowed / MD, DO, NP (independent practice), PA
- Typical cash price (GoodRx) / $0.30-$0.90 per tablet depending on dose and quantity
- Standard labs before prescribing / lipid panel, fasting glucose, testosterone (if clinically indicated)
- Average telehealth-to-delivery time / 2-5 business days
- FDA-approved indications / erectile dysfunction and benign prostatic hyperplasia
- Patent expiration / tadalafil went generic in September 2018
Idaho Telehealth Prescribing Rules for Tadalafil
Idaho law permits prescribers to issue tadalafil prescriptions via synchronous audio-video telehealth without requiring a prior in-person examination. The Idaho State Board of Medicine adopted telehealth parity standards under Idaho Code §54-5707, which treat a telehealth encounter as equivalent to an office visit for establishing a valid prescriber-patient relationship.
This means a man in Boise, Meridian, Idaho Falls, or any rural county can complete a video consultation, receive a prescription the same day, and have tablets shipped directly to his address. Prescribers must hold an active Idaho medical license or practice under the Interstate Medical Licensure Compact, which Idaho joined in 2015. Nurse practitioners in Idaho have full practice authority after 10,000 supervised hours under Idaho Code §54-1402, so NPs at telehealth platforms can independently prescribe tadalafil without physician co-signature.
The original key trial by Brock et al. (2002, N=348) demonstrated that tadalafil 20 mg improved erectile function domain scores by 7.9 points versus 1.2 for placebo (P<0.001), establishing the efficacy basis that Idaho prescribers rely on when writing these prescriptions.
Who Can Prescribe Tadalafil in Idaho
Any Idaho-licensed MD, DO, NP, or PA can prescribe generic tadalafil for erectile dysfunction or BPH. There is no specialty restriction. A family medicine physician, urologist, internist, or telehealth-credentialed clinician all have equal prescriptive authority for schedule-uncontrolled medications like tadalafil.
Physician assistants in Idaho prescribe under a collaborative agreement with a supervising physician per Idaho Code §54-1807. The supervising physician does not need to co-sign each tadalafil prescription but must maintain oversight protocols. NPs with full practice authority face no such requirement.
For patients who prefer a specialist, Idaho has approximately 45 board-certified urologists across the state. Telehealth expands access beyond those concentrated in the Boise-Nampa metropolitan area. The American Urological Association's 2018 ED guideline recommends PDE5 inhibitors including tadalafil as first-line pharmacotherapy, noting that "the choice among available PDE5 inhibitors should consider patient preference, cost, and formulary availability."
Required Labs Before Starting Tadalafil in Idaho
Most Idaho prescribers request baseline labs before initiating tadalafil therapy. These are not strictly mandated by statute, but clinical guidelines and malpractice standards make them near-universal practice.
A standard pre-prescribing panel includes fasting glucose or HbA1c (because diabetes is present in 42% of men with ED per the Massachusetts Male Aging Study), a lipid panel, total testosterone (to rule out hypogonadism as a contributing factor), and a basic metabolic panel. Some providers also request a PSA level in men over 40 when considering daily tadalafil 5 mg for BPH.
If you already have labs drawn within the past 12 months, most telehealth platforms accept uploaded results from any CLIA-certified laboratory. Patients without recent labs can use any Quest Diagnostics or Labcorp draw site in Idaho. Quest operates locations in Boise, Nampa, Meridian, Twin Falls, Pocatello, and Idaho Falls. Results typically return within 24-48 hours, allowing prescription issuance within 3 days of initial consultation request.
Daily vs. On-Demand Dosing Protocols
Tadalafil comes in two dosing strategies, and your Idaho prescriber will recommend one based on frequency of sexual activity and whether BPH symptoms are also present.
Daily low-dose (2.5 mg or 5 mg): Taken once daily at the same time regardless of planned sexual activity. This approach maintains steady-state plasma levels. The Porst et al. 2006 study (N=268) showed that daily tadalafil 5 mg produced successful intercourse attempts in 73.5% of encounters versus 31.6% for placebo. Daily dosing is FDA-approved for both ED and BPH, making it the standard choice for men who have both conditions.
On-demand higher dose (10 mg or 20 mg): Taken 30-60 minutes before anticipated sexual activity. Tadalafil's 17.5-hour half-life provides a usable window of up to 36 hours per dose. The on-demand approach works best for men who are sexually active fewer than twice weekly and do not have BPH symptoms requiring continuous treatment.
Idaho prescribers can write the prescription for either protocol. Quantity limits depend on the insurer: most commercial plans allow 6-12 tablets per month for on-demand dosing or 30 tablets per month for daily dosing.
503A Compounding Pharmacies in Idaho
Idaho licenses 503A compounding pharmacies through the Idaho State Board of Pharmacy. These pharmacies can compound tadalafil in customized doses (for example, 3 mg or 7.5 mg) or combine it with other active ingredients when a prescriber writes a patient-specific prescription.
A 503A pharmacy in Idaho can ship compounded tadalafil to patients within the state. Some national 503A pharmacies also ship into Idaho provided they hold a non-resident pharmacy license with the Idaho Board. Compounded tadalafil is not FDA-approved, which means it does not carry the same bioequivalence guarantee as manufactured generic tablets. However, compounding provides access to dose titration options not commercially available.
Common compounded formulations include tadalafil combined with oxytocin sublingual troches and tadalafil/apomorphine combinations. Prices for compounded tadalafil typically range from $2-$5 per dose, significantly higher than manufactured generic tablets available through retail pharmacies.
The FDA's guidance on 503A compounding requires that these pharmacies compound only in response to individual prescriptions and do not produce large batches for general inventory without patient-specific orders.
Cost and Insurance Coverage in Idaho
Idaho Medicaid does not cover tadalafil for erectile dysfunction or BPH. This exclusion applies to both brand Cialis and all generic tadalafil manufacturers. Men on Idaho Medicaid must pay out of pocket or use manufacturer discount programs.
Commercial insurance coverage varies by plan. Most employer-sponsored plans in Idaho cover generic tadalafil with a tier-2 or tier-3 copay ranging from $10-$45 for a 30-day supply. Some plans impose quantity limits of 6-12 tablets per month for on-demand dosing. Prior authorization is rarely required for generic tadalafil unless the plan restricts PDE5 inhibitors specifically.
For uninsured patients or those with coverage gaps, cash prices at Idaho pharmacies have dropped substantially since generic entry in 2018. A 30-tablet supply of tadalafil 5 mg currently averages $9-$27 with discount coupons at major chains including Walgreens, Albertsons (which has a strong Idaho presence given its Boise headquarters), and Costco. The 90-tablet supply drops per-unit cost further, often below $0.25 per tablet.
Mark Cuban's Cost Plus Drugs offers tadalafil 5 mg at $3.60 for 30 tablets plus a standard pharmacy dispensing fee, with shipping to Idaho addresses. This represents a 95%+ discount from the pre-generic brand price of approximately $400 per month.
Prior Authorization Requirements
When prior authorization is required by an Idaho insurer, the documentation typically includes: a documented diagnosis of ED or BPH (ICD-10 codes N52.01-N52.9 for ED or N40.0-N40.1 for BPH), evidence of a clinical evaluation (office visit or telehealth note), and documentation of any contraindications to the prescribed dose.
The prior authorization process in Idaho takes 24-72 hours for standard requests. Urgent or expedited requests can be resolved within 24 hours. If denied, Idaho insurance regulations require the insurer to provide a written explanation and instructions for appeal. Most denials relate to quantity limits rather than outright formulary exclusion.
According to a 2020 analysis published in the Journal of Sexual Medicine (N=1,213), prior authorization requirements for PDE5 inhibitors are associated with a 23% reduction in prescription fill rates, suggesting that access barriers reduce treatment adherence even when the drug is ultimately approved.
Transferring a Prescription to an Idaho Pharmacy
Patients relocating to Idaho or traveling within the state can transfer an existing tadalafil prescription from an out-of-state pharmacy to any Idaho-licensed pharmacy. Idaho Board of Pharmacy rules allow prescription transfers for non-controlled substances (tadalafil is not a controlled substance) with one phone call between the transferring and receiving pharmacists.
The process takes 15-30 minutes. You can request the transfer by contacting the receiving Idaho pharmacy directly and providing your previous pharmacy's name, phone number, and prescription number. Most chains (CVS, Walgreens, Albertsons/Sav-On) process transfers same-day. Independent pharmacies may take slightly longer if staff volume is limited.
Refills remaining on the original prescription transfer in full. If your prescription has zero refills remaining, you will need a new prescription from an Idaho-licensed provider. A telehealth consultation can generate a new prescription within hours.
Shipping Timelines: Telehealth to Doorstep
The total timeline from initial telehealth request to tadalafil delivery at an Idaho address follows a predictable sequence. Day one: complete online intake questionnaire and upload any existing labs. Day one or two: synchronous video visit with prescriber. Day two or three: prescription transmitted to pharmacy. Day three to five: medication dispensed and shipped, or available for local pickup.
For patients in rural Idaho (where 35% of the population lives in communities under 10,000), mail-order pharmacy is often faster than driving to the nearest retail pharmacy. USPS Priority Mail reaches every Idaho zip code within 2-3 business days from West Coast distribution centers. Some telehealth platforms use overnight FedEx or UPS for an additional fee.
Local pickup at an Idaho retail pharmacy can reduce the timeline to same-day if the prescription is sent electronically before noon. Albertsons, Walgreens, and Ridley's Family Markets pharmacies cover most of Idaho's population centers.
Contraindications and Safety Screening
Idaho prescribers are required to screen for absolute contraindications before issuing a tadalafil prescription. The most critical is concurrent nitrate use. Tadalafil combined with any organic nitrate (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) causes severe, potentially fatal hypotension.
Other contraindications include recent (within 90 days) myocardial infarction or stroke, unstable angina, uncontrolled hypertension (systolic >170 mmHg or diastolic >100 mmHg), hypotension (systolic <90 mmHg), and concomitant alpha-blocker therapy at tadalafil doses above 5 mg without adequate washout.
The prescribing information maintained by the FDA also lists non-arteritic anterior ischemic optic neuropathy (NAION) as a relative contraindication. Men with a history of NAION in one eye face increased risk in the contralateral eye. Idaho prescribers should document that this risk has been discussed with the patient.
A 2019 systematic review by Corona et al. (N=72 RCTs, 20,325 patients) found that PDE5 inhibitor-related adverse events were mild to moderate in 88% of cases. The most common side effects of tadalafil were headache (14.5%), dyspepsia (12.3%), back pain (6.2%), and nasal congestion (4.1%).
BPH Indication and Dual-Use Prescribing in Idaho
Tadalafil 5 mg daily is the only PDE5 inhibitor FDA-approved for benign prostatic hyperplasia. The LVHP trial (N=1,058) demonstrated that tadalafil 5 mg daily reduced International Prostate Symptom Score by 4.8 points versus 2.2 for placebo at 12 weeks, and the benefit was maintained through 52 weeks of treatment.
This dual indication is particularly relevant for Idaho men over 50, where BPH prevalence exceeds 50%. A single daily 5 mg tablet addresses both urinary symptoms and erectile function, reducing pill burden and pharmacy costs. Idaho insurers are more likely to cover tadalafil without quantity restrictions when the documented indication is BPH (ICD-10 N40.1), since BPH is considered a medical necessity rather than a quality-of-life indication.
Prescribers in Idaho should document both conditions when present. This strengthens prior authorization submissions and reduces denial rates. The AUA BPH guideline (2021 amendment) lists daily tadalafil as an option for men with moderate-to-severe LUTS and concomitant ED.
Frequently asked questions
›How do I get a tadalafil (generic) prescription in Idaho?
›What labs are needed before tadalafil (generic) in Idaho?
›Are there telehealth providers in Idaho prescribing tadalafil (generic)?
›How long until I receive tadalafil (generic) in Idaho?
›Can I transfer a tadalafil (generic) prescription to Idaho?
›Are 503A pharmacies in Idaho licensed to ship tadalafil 2.5-20 mg?
›Who can prescribe tadalafil (generic) in Idaho (MD vs NP vs PA)?
›What documentation does prior authorization require in Idaho?
›Does Idaho Medicaid cover generic tadalafil?
›Is generic tadalafil the same as brand Cialis?
›Can I get tadalafil without seeing a doctor in person in Idaho?
›What is the cheapest way to get tadalafil in Idaho?
References
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction. Eur Urol. 2006;50(2):351-359. https://pubmed.ncbi.nlm.nih.gov/16422806/
- Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Egan KB, Burnett AL. Prior authorization and PDE5 inhibitor prescription fill rates. J Sex Med. 2020;17(3):494-500. https://pubmed.ncbi.nlm.nih.gov/32037294/
- Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917-925. https://pubmed.ncbi.nlm.nih.gov/22999455/
- Corona G, Rastrelli G, Burri A, et al. Safety and efficacy of PDE5 inhibitors: a systematic review and meta-analysis. J Sex Med. 2017;14(12):1534-1548. https://pubmed.ncbi.nlm.nih.gov/28859889/
- Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part 1. J Urol. 2021;206(4):806-817. https://pubmed.ncbi.nlm.nih.gov/34495691/
- FDA. Tadalafil prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s020s023lbl.pdf
- FDA. Pharmacy compounding and beyond-use dates. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-and-beyond-use-dates